This stimulating collection of essays, a product of face-to-face dialogues among anthropologists, sociologists, and philosopher-historians, focuses on the newly created biomedical technologies and their application in practice. Drawing on ethnographic and historical case studies, the authors show how biomedical technologies are produced through the agencies of tools and techniques, scientists and doctors, funding bodies, patients, clients, and the public. Despite shared concerns, the contributions reveal that the authors have achieved no consensus about the objectives of their research. Deep epistemological divides clearly remain, making for provocative reading.

Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.

The very rapid pace of advances in biomedical research promises us a wide range of new drugs, medical devices, and clinical procedures. The extent to which these discoveries will benefit the public, however, depends in large part on the methods we choose for developing and testing them. Modern Methods of Clinical Investigation focuses on strategies for clinical evaluation and their role in uncovering the actual benefits and risks of medical innovation. Essays explore differences in our current systems for evaluating drugs, medical devices, and clinical procedures; health insurance databases as a tool for assessing treatment outcomes; the role of the medical profession, the Food and Drug Administration, and industry in stimulating the use of evaluative methods; and more. This book will be of special interest to policymakers, regulators, executives in the medical industry, clinical researchers, and physicians.

Examines a range of current innovative health technologies, exploring how far they change the boundaries between the body, health, technology relationship, and assessing the contribution a critical social science can make towards our understanding of this shift.

On March 3-4, 2016, the National Academies of Sciences, Engineering, and Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop in Washington, DC, bringing together key stakeholders to discuss opportunities for improving the integrity, efficiency, and validity of clinical trials for nervous system disorders. Participants in the workshop represented a range of diverse perspectives, including individuals not normally associated with traditional clinical trials. The purpose of this workshop was to generate discussion about not only what is feasible now, but what may be possible with the implementation of cutting-edge technologies in the future.

In 1996, the Institute of Medicine (IOM) released its report Telemedicine: A Guide to Assessing Telecommunications for Health Care. In that report, the IOM Committee on Evaluating Clinical Applications of Telemedicine found telemedicine is similar in most respects to other technologies for which better evidence of effectiveness is also being demanded. Telemedicine, however, has some special characteristics-shared with information technologies generally-that warrant particular notice from evaluators and decision makers. Since that time, attention to telehealth has continued to grow in both the public and private sectors. Peer-reviewed journals and professional societies are devoted to telehealth, the federal government provides grant funding to promote the use of telehealth, and the private technology industry continues to develop new applications for telehealth. However, barriers remain to the use of telehealth modalities, including issues related to reimbursement, licensure, workforce, and costs. Also, some areas of telehealth have developed a stronger evidence base than others. The Health Resources and Service Administration (HRSA) sponsored the IOM in holding a workshop in Washington, DC, on August 8-9 2012, to examine how the use of telehealth technology can fit into the U.S. health care system. HRSA asked the IOM to focus on the potential for telehealth to serve geographically isolated individuals and extend the reach of scarce resources while also emphasizing the quality and value in the delivery of health care services. This workshop summary discusses the evolution of telehealth since 1996, including the increasing role of the private sector, policies that have promoted or delayed the use of telehealth, and consumer acceptance of telehealth. The Role of Telehealth in an Evolving Health Care Environment: Workshop Summary discusses the current evidence base for telehealth, including available data and gaps in data; discuss how technological developments, including mobile telehealth, electronic intensive care units, remote monitoring, social networking, and wearable devices, in conjunction with the push for electronic health records, is changing the delivery of health care in rural and urban environments. This report also summarizes actions that the U.S. Department of Health and Human Services (HHS) can undertake to further the use of telehealth to improve health care outcomes while controlling costs in the current health care environment.

Improving healthcare and staying healthy is one of the most discussed and important issues in our society. Technology has played and will play an important role in many aspects of the healthcare system, and it offers new and better ways to solve the key health problems of the new century. This book describes valued contributions of technology for improving hospital and home healthcare, and gives a perspective on how they will influence critical aspects of future medical care. It provides an overview and discussion of trends, presents the state-of-the-art of important research areas, and highlights recent breakthrough results in selected fields, giving an outlook on game-changing developments in the coming decades. The material is arranged in 6 parts and a total of 31 chapters. The healthcare areas addressed are: General advances and trends in healthcare technology, diagnostic imaging, integration of imaging and therapy, molecular medicine, medical information technology and personal healthcare.

New Technologies and Emerging Spaces of Care provides the latest practice-oriented qualitative research and innovative conceptual discussions of how health and health care systems are currently dealing with complex transformations and varied reforms. Exploring and analysing the social and cultural impact of new technologies, this book examines the societal relevance of new technologies of care and the manner in which technological innovations configure and reconfigure institutionalized spaces of care. It addresses issues of social control, accountability, surveillance and disciplining; diverging patterns of inclusion and exclusion; new relations and subjectivities of patients and care givers; the relation between private and public forms of care and the practices and concerns generated by new technologies at the individual as well as the societal level. Presenting sophisticated theoretical discussions and detailed empirical case studies, New Technologies and Emerging Spaces of Care analyses, compares and evaluates on a transnational level the role and impact of (assistive) technologies for elderly and disabled people on the concepts and practices of spaces of care. A critical understanding of contemporary practices of care, that cuts through the growing conceptual barriers between social and medical models of care studies, this book will be of interest to those interested in new technologies, health care and social space of care. Specifically, it will appeal to scholars of science and technology studies, medical sociology and the sociology of the body, social inequality and exclusion, health and care studies, gerontology and disability studies.

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.